Last10K.com

Imv Inc. (IMV) SEC Filing 6-K Foreign Issuer Report for the period ending Friday, December 16, 2022

Imv Inc.

HISTORY TOOLS
CIK: 1734768 Ticker: IMV

View differences made from one to another to evaluate Imv Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Imv Inc..

Continue

Assess how Imv Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Imv Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Imv Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: News Release Dated December 16, 2022
Ticker: IMV
CIK: 1734768
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001176256-22-000333
Submitted to the SEC: Fri Dec 16 2022 11:40:40 AM EST
Accepted by the SEC: Fri Dec 16 2022
Period: Friday, December 16, 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/imv/0001176256-22-000333.htm